While the engraftment rates were similar between cohorts, the leukemia burden was significantly reduced in mice transplanted with MOLM-13 ABCC1-knockout cells upon AZD-4320 treatment compared to vehicle treatment and to MOLM-13 AAVS1.1 control cells (Fig. 3D, E). This evidence concerns the gene ABCC1 and leukemia.